Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events.
Rimola J, Díaz-González Á, Darnell A, Varela M, Pons F, Hernandez-Guerra M, Delgado M, Castroagudin J, Matilla A, Sangro B, Rodriguez de Lope C, Sala M, Gonzalez C, Huertas C, Minguez B, Ayuso C, Bruix J, Reig M.
Rimola J, et al.
Hepatology. 2018 Feb;67(2):612-622. doi: 10.1002/hep.29515. Epub 2018 Jan 2.
Hepatology. 2018.
PMID: 28898447
Free article.